Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
Stock Summary
Top Correlated Resources
001630.KS
Top 10 Correlated ETFs
001630.KS
Top 10 Correlated Stocks
001630.KS
Financial details
Company Rating
Buy
Market Cap
246.39B
Income
2.3B
Revenue
906.92B
Book val./share
107315.97
Cash/share
27273.53
Dividend
1400
Dividend %
2.78%
Employees
40
Optionable
No
Shortable
Yes
Earnings
14 Nov 2022
P/E
108.07
Forward P/E
-
PEG
-11.13
P/S
0.27
P/B
0.47
P/C
1.85
P/FCF
-5.45
Quick Ratio
0.38
Current Ratio
1.2
Debt / Equity
0.3
LT Debt / Equity
0.2
-
-
EPS (TTM)
454.51
EPS next Y
-
EPS next Q
-
EPS this Y
-79.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-20.03%
Revenue last 5Y
15.49%
Revenue Q/Q
-5.63%
EPS Q/Q
-222.25%
-
-
-
-
SMA20
-12.23%
SMA50
-9.2%
SMA100
-24.47%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
45%
Oper. Margin
-
Profit Margin
-
Payout
300%
Shs Outstand
4.89M
Shs Float
2.55M
-
-
-
-
Target Price
-
52W Range
49050.0-86000.0
52W High
-41.4%
52W Low
+2.75%
RSI
20.2
Rel Volume
0.52
Avg Volume
3.33K
Volume
1.72K
Perf Week
-9.19%
Perf Month
-19.36%
Perf Quarter
-32.08%
Perf Half Y
-29.21%
-
-
-
-
Beta
0.479211
-
-
Volatility
1675.64%, 3526.71%
Prev Close
-0.98%
Price
50400
Change
1.2%
Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 91.69K | 106.01K | 143.85K | 171.36K | 184.91K | |
| Net income per share | 9.77K | 5.48K | 8.99K | 15.71K | 3.19K | |
| Operating cash flow per share | 11.75K | 7.57K | 22.21K | 13.29K | 8.08K | |
| Free cash flow per share | 8.15K | -2.97K | -3.71K | -10.26K | -12.52K | |
| Cash per share | 21.63K | 13.16K | 18.74K | 21.47K | 28.94K | |
| Book value per share | 83.18K | 85.68K | 93.6K | 107.87K | 108.03K | |
| Tangible book value per share | 124.87K | 128.62K | 142.52K | 162.34K | 162.64K | |
| Share holders equity per share | 83.18K | 85.68K | 93.6K | 107.87K | 108.03K | |
| Interest debt per share | 9.98K | 14.14K | 31.35K | 44.66K | 69.83K | |
| Market cap | 386.9B | 307.61B | 541.06B | 543.32B | 341.02B | |
| Enterprise value | 379.13B | 342.61B | 654.83B | 725.53B | 606.49B | |
| P/E ratio | 8.06 | 11.2 | 12.02 | 6.91 | 21.32 | |
| Price to sales ratio | 0.86 | 0.58 | 0.75 | 0.63 | 0.37 | |
| POCF ratio | 6.7 | 8.11 | 4.86 | 8.16 | 8.43 | |
| PFCF ratio | 9.66 | -20.66 | -29.13 | -10.57 | -5.44 | |
| P/B Ratio | 0.95 | 0.72 | 1.15 | 1.01 | 0.63 | |
| PTB ratio | 0.95 | 0.72 | 1.15 | 1.01 | 0.63 | |
| EV to sales | 0.84 | 0.65 | 0.91 | 0.85 | 0.65 | |
| Enterprise value over EBITDA | 4.43 | 5.07 | 6.95 | 5.08 | 10.43 | |
| EV to operating cash flow | 6.56 | 9.03 | 5.88 | 10.9 | 14.99 | |
| EV to free cash flow | 9.47 | -23.01 | -35.26 | -14.12 | -9.68 | |
| Earnings yield | 0.12 | 0.09 | 0.08 | 0.14 | 0.05 | |
| Free cash flow yield | 0.1 | -0.05 | -0.03 | -0.09 | -0.18 | |
| Debt to equity | 0 | 0.04 | 0.1 | 0.16 | 0.3 | |
| Debt to assets | 0.22 | 0.23 | 0.31 | 0.33 | 0.39 | |
| Net debt to EBITDA | -0.09 | 0.52 | 1.21 | 1.28 | 4.56 | |
| Current ratio | 2.32 | 2.02 | 1.4 | 1.41 | 1.38 | |
| Interest coverage | 27.25 | 36.84 | 29.06 | 25.65 | 7.89 | |
| Income quality | 1.2 | 1.38 | 2.47 | 0.85 | 2.53 | |
| Dividend Yield | 0.03 | 0.04 | 0.02 | 0.02 | 0.03 | |
| Payout ratio | 0.21 | 0.47 | 0.21 | 0.13 | 0.68 | |
| Sales general and administrative to revenue | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Intangibles to total assets | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | -0.31 | -1.39 | -1.17 | -1.77 | -2.55 | |
| Capex to revenue | -0.04 | -0.1 | -0.18 | -0.14 | -0.11 | |
| Capex to depreciation | -0.74 | -2.19 | -4.72 | -3.89 | -2.89 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 135.19K | 102.79K | 137.58K | 195.28K | 88.11K | |
| ROIC | 0.06 | 0.07 | 0.1 | 0.09 | 0.03 | |
| Return on tangible assets | 0.06 | 0.03 | 0.04 | 0.06 | 0.01 | |
| Graham Net | -5.6K | -17.27K | -36.37K | -45.62K | -58.87K | |
| Working capital | 170.01B | 145.45B | 96.31B | 114B | 119.16B | |
| Tangible asset value | 613.87B | 644.37B | 714.02B | 812.94B | 814.45B | |
| Net current asset value | 119.97B | 88.08B | 1.08B | -23.76B | -90.8B | |
| Invested capital | 0.12 | 0.16 | 0.33 | 0.41 | 0.64 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 54.13B | 56.37B | 60.87B | 69.91B | 71.54B | |
| Average inventory | 127.02B | 130.4B | 140.77B | 164.39B | 170.16B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 49.32 | 47.63 | 48.26 | 57.45 | 55.11 | |
| Days of inventory on hand | 115.33 | 107.23 | 109.09 | 135.07 | 132.52 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 7.4 | 7.66 | 7.56 | 6.35 | 6.62 | |
| Inventory turnover | 3.16 | 3.4 | 3.35 | 2.7 | 2.75 | |
| ROE | 0.12 | 0.06 | 0.1 | 0.15 | 0.03 | |
| Capex per share | -3.6K | -10.54K | -25.92K | -23.55K | -20.6K |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 47.09K | 46.47K | 43K | 47.82K | 45.58K | |
| Net income per share | 1.35K | 533 | 53.64 | 593.88 | -726 | |
| Operating cash flow per share | -2.22K | 4.8K | 2.07K | -1.21K | 3.44K | |
| Free cash flow per share | -7.24K | -1.52K | -2.29K | -6.17K | 833.64 | |
| Cash per share | 18.59K | 27.02K | 29.15K | 0 | 27.27K | |
| Book value per share | 108.95K | 109.01K | 108.81K | 107.71K | 107.32K | |
| Tangible book value per share | 163.6K | 163.97K | 163.82K | 166.07K | 159.48K | |
| Share holders equity per share | 108.95K | 109.01K | 108.81K | 107.71K | 107.32K | |
| Interest debt per share | 52.7K | 65.63K | 69.58K | -421.16 | 80.19K | |
| Market cap | 536.6B | 424.07B | 380.33B | 356.46B | 279.09B | |
| Enterprise value | 746.72B | 659B | 645.8B | 356.46B | 597.14B | |
| P/E ratio | 19.92 | 40.01 | 356.57 | 30.18 | -19.52 | |
| Price to sales ratio | 2.28 | 1.84 | 1.78 | 1.5 | 1.24 | |
| POCF ratio | -48.38 | 17.77 | 36.99 | -59.01 | 16.48 | |
| PFCF ratio | -14.86 | -55.99 | -33.48 | -11.62 | 68.01 | |
| P/B Ratio | 0.99 | 0.78 | 0.7 | 0.67 | 0.53 | |
| PTB ratio | 0.99 | 0.78 | 0.7 | 0.67 | 0.53 | |
| EV to sales | 3.18 | 2.85 | 3.02 | 1.5 | 2.66 | |
| Enterprise value over EBITDA | 47.01 | 43.11 | 85.49 | 30.03 | 61.59 | |
| EV to operating cash flow | -67.32 | 27.61 | 62.8 | -59.01 | 35.26 | |
| EV to free cash flow | -20.68 | -87 | -56.85 | -11.62 | 145.52 | |
| Earnings yield | 0.01 | 0.01 | 0 | 0.01 | -0.01 | |
| Free cash flow yield | -0.07 | -0.02 | -0.03 | -0.09 | 0.01 | |
| Debt to equity | 0.18 | 0.27 | 0.3 | 0 | 0.3 | |
| Debt to assets | 0.34 | 0.37 | 0.39 | 0.39 | 0.41 | |
| Net debt to EBITDA | 13.23 | 15.37 | 35.14 | 0 | 32.8 | |
| Current ratio | 1.36 | 1.42 | 1.38 | 1.29 | 1.2 | |
| Interest coverage | 5.59 | 4.45 | -1.05 | 0.53 | -3.71 | |
| Income quality | -1.65 | 9.01 | 38.56 | -2.05 | -4.74 | |
| Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
| Payout ratio | 0 | 0 | 10.13 | 0 | 0 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.03 | 0.46 | 0.03 | |
| Research and developement to revenue | 0.02 | 0.02 | 0.04 | 0 | 0.02 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0 | 0.02 | |
| Capex to operating cash flow | 2.26 | -1.32 | -2.1 | 4.08 | -0.76 | |
| Capex to revenue | -0.11 | -0.14 | -0.1 | -0.1 | -0.06 | |
| Capex to depreciation | -2.75 | -3.4 | -2.46 | -2.25 | -1.19 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 57.51K | 36.16K | 11.46K | 37.94K | 41.87K | |
| ROIC | 0.01 | 0.01 | 0 | 0 | -0.01 | |
| Return on tangible assets | 0.01 | 0 | 0 | 0 | 0 | |
| Graham Net | -51.47K | -58.2K | -59.29K | -104.46K | -69.05K | |
| Working capital | 104.76B | 128.25B | 119.16B | 91.59B | 71.81B | |
| Tangible asset value | 816.61B | 815.18B | 814.45B | 0 | 785.01B | |
| Net current asset value | -40.82B | -69.22B | -90.8B | -116.14B | -134.54B | |
| Invested capital | 0.48 | 0.6 | 0.64 | 0 | 0.74 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 44.95 | 37.73 | 58.07 | 0 | 43.99 | |
| Days of inventory on hand | 128.59 | 111.67 | 139.63 | 0 | 123.96 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 2 | 2.39 | 1.55 | 0 | 2.05 | |
| Inventory turnover | 0.7 | 0.81 | 0.64 | 0 | 0.73 | |
| ROE | 0.01 | 0 | 0 | 0.01 | -0.01 | |
| Capex per share | -5.01K | -6.32K | -4.35K | -4.96K | -2.61K |
Frequently Asked Questions
What is Chong Kun Dang Holdings Corp. stock symbol ?
Chong Kun Dang Holdings Corp. is a US stock and trading under the symbol 001630.KS
What is Chong Kun Dang Holdings Corp. stock quote today ?
Chong Kun Dang Holdings Corp. stock price is $50400 today.
Is Chong Kun Dang Holdings Corp. stock public?
Yes, Chong Kun Dang Holdings Corp. is a publicly traded company.
Company Profile
- Volume Average 3.33K
- Market Capitalization 246.39B
- Employee 40
- Headquarters Seoul,US
- IPO Date 2000-01-04
-
Website
https://www.ckd-holdings.com/company/summary.do 
Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. The company was founded in 1941 and is headquartered in Seoul, South Korea.
